Guardant Health appointed experienced leaders, but the filing reports no change to its business results. The director's $500,000 stock award and $60,000 yearly cash retainer add costs.
Their experience may help with oversight and accounting. The filing also lists a $500,000 stock award and a $60,000 yearly cash retainer for the director. It reports no change to Guardant Health's products, sales, or results.
Dexcom appears in the filing as Kevin Sayer's current board connection and former employer. The filing reports no change to Dexcom, so its outlook is unchanged.
SailPoint appears only in Robert Parks's work history. The filing reports no change to SailPoint, so its outlook is unchanged.
NetApp appears only in Robert Parks's work history. The filing reports no change to NetApp, so its outlook is unchanged.
IQVIA appears only in Robert Parks's work history. The filing reports no change to IQVIA, so its outlook is unchanged.
Follow Guardant Health, Inc. (GH) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for GH